Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01701102 · ClinicalTrials.gov registry record · NA
Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery
A NA study of Arthroscopic Knee Surgery, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT01701102 is a NA study of Arthroscopic Knee Surgery that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 56 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01701102, a NA study of Arthroscopic Knee Surgery, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
Prolonged motor block and delayed ability to walk are limitations of spinal anesthesia in ambulatory (same-day) surgery. This can be improved by lowering the dose of local anesthetic (a medication that, when injected around nerves, blocks nerve conduction, resulting in numbness and weakness) used in the spine, but too low a dose can result in an incomplete block (inadequate anesthesia) in some patients. There is evidence that adding a low dose of fentanyl, a narcotic, to mepivacaine enhances the anesthetic effect. The purpose of this study is to determine the lowest dose of mepivacaine, a local anesthetic, when combined with fentanyl, for which spinal anesthesia is adequate for ambulatory knee arthroscopy.
Conditions Studied
Interventions
- PROCEDURE Mepivacaine (24 mg) plus fentanyl
- PROCEDURE Mepivacaine (27 mg) plus fentanyl
- PROCEDURE Mepivacaine (30 mg) plus fentanyl
- PROCEDURE Mepivacaine
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01701102
The ClinicalTrials.gov registry entry for NCT01701102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthroscopic Knee Surgery appearing as the primary indexed condition, and to 4 interventions - of which Mepivacaine (24 mg) plus fentanyl is the first listed.
NCT01701102 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01701102 about?
NCT01701102 is a clinical study titled "Study to Find Optimal Dose of Local Spinal Anesthetic (Mepivacaine) Combined With Narcotic (Fentanyl) For Knee Surgery". Prolonged motor block and delayed ability to walk are limitations of spinal anesthesia in ambulatory (same-day) surgery. This can be improved by lowering the dose of local anesthetic (a medication that, when injected around nerves, blocks nerve conduction, resulting in numbness and weakness) used in...
What is the current status of trial NCT01701102?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2011-12. Estimated completion is 2013-12.
What conditions does trial NCT01701102 study?
This clinical trial studies the following conditions: Arthroscopic Knee Surgery.
What interventions are being tested in trial NCT01701102?
The interventions under investigation include: Mepivacaine (24 mg) plus fentanyl (PROCEDURE), Mepivacaine (27 mg) plus fentanyl (PROCEDURE), Mepivacaine (30 mg) plus fentanyl (PROCEDURE), Mepivacaine (PROCEDURE).
Who is sponsoring clinical trial NCT01701102?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01701102 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.